EE04259B1 - Survestatud doseerivad inhalaatorid (MDId) - Google Patents

Survestatud doseerivad inhalaatorid (MDId)

Info

Publication number
EE04259B1
EE04259B1 EEP200100276A EEP200100276A EE04259B1 EE 04259 B1 EE04259 B1 EE 04259B1 EE P200100276 A EEP200100276 A EE P200100276A EE P200100276 A EEP200100276 A EE P200100276A EE 04259 B1 EE04259 B1 EE 04259B1
Authority
EE
Estonia
Prior art keywords
mdis
metered dose
dose inhalers
pressurized metered
pressurized
Prior art date
Application number
EEP200100276A
Other languages
English (en)
Estonian (et)
Inventor
Lewis David
Ganderton David
Meakin Brian
Ventura Paolo
Brambilla Gaetano
Garzia Raffaella
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26331622&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04259(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ITMI982559 external-priority patent/IT1303789B1/it
Priority claimed from IT1999MI001712 external-priority patent/IT1313582B1/it
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of EE200100276A publication Critical patent/EE200100276A/xx
Publication of EE04259B1 publication Critical patent/EE04259B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Measurement Of Radiation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100276A 1998-11-25 1999-11-23 Survestatud doseerivad inhalaatorid (MDId) EE04259B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI982559 IT1303789B1 (it) 1998-11-25 1998-11-25 "inalatori dosati pressurizzati"
IT1999MI001712 IT1313582B1 (it) 1999-07-30 1999-07-30 Inalatori dosati pressurizzati.
PCT/EP1999/009002 WO2000030608A1 (en) 1998-11-25 1999-11-23 Pressurised metered dose inhalers (mdi)

Publications (2)

Publication Number Publication Date
EE200100276A EE200100276A (et) 2002-12-16
EE04259B1 true EE04259B1 (et) 2004-04-15

Family

ID=26331622

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100276A EE04259B1 (et) 1998-11-25 1999-11-23 Survestatud doseerivad inhalaatorid (MDId)

Country Status (36)

Country Link
US (8) US7347199B1 (es)
EP (4) EP1674079A3 (es)
JP (1) JP2002530156A (es)
KR (1) KR100696746B1 (es)
CN (1) CN1200690C (es)
AR (1) AR021391A1 (es)
AT (2) ATE485812T1 (es)
AU (1) AU764696C (es)
BG (1) BG65596B1 (es)
BR (1) BR9916868B1 (es)
CA (2) CA2352484C (es)
CO (1) CO5170487A1 (es)
CY (1) CY1105356T1 (es)
CZ (1) CZ301305B6 (es)
DE (3) DE29923839U1 (es)
DK (1) DK1131051T3 (es)
DZ (1) DZ2947A1 (es)
EA (1) EA004132B1 (es)
EE (1) EE04259B1 (es)
EG (1) EG25278A (es)
ES (1) ES2255767T3 (es)
GE (1) GEP20033129B (es)
HK (1) HK1040063B (es)
HU (1) HU226735B1 (es)
IL (3) IL143294A0 (es)
MA (1) MA26764A1 (es)
NO (1) NO330194B1 (es)
NZ (2) NZ527190A (es)
PL (2) PL200658B1 (es)
SA (1) SA99200825B1 (es)
SI (1) SI1131051T1 (es)
SK (1) SK285246B6 (es)
TN (1) TNSN99220A1 (es)
TR (2) TR200704956T2 (es)
TW (1) TWI226247B (es)
WO (1) WO2000030608A1 (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6739333B1 (en) 1999-05-26 2004-05-25 Boehringer Ingelheim Pharma Kg Stainless steel canister for propellant-driven metering aerosols
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
ME00220B (me) * 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020085978A1 (en) * 2000-11-10 2002-07-04 Mina Buenafe Degradation-resistant glucocorticosteroid formulations
GB0106046D0 (en) * 2001-03-12 2001-05-02 Glaxo Group Ltd Canister
EP1241113A1 (en) * 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
SI1273292T1 (en) * 2001-07-02 2004-12-31 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
ME00077B (me) * 2002-03-01 2010-06-10 Chiesi Farm Spa Formoterol najfiniji preparat
US20040126325A1 (en) * 2002-03-12 2004-07-01 David Lewis Medicinal aerosol solution formulation products with improved chemical stability
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
AU2003293528A1 (en) * 2003-02-04 2004-09-06 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
ATE390125T1 (de) 2003-03-20 2008-04-15 Boehringer Ingelheim Pharma Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
GB0311701D0 (en) * 2003-05-21 2003-06-25 Karib Kemi Pharm Liited Improved metered dose inhaler product
EP1641682B1 (en) 2003-06-24 2011-01-05 Cipla Limited Pharmaceutical dispensing aid
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
JP2007509147A (ja) * 2003-10-20 2007-04-12 シェーリング　コーポレイション 薬学的エアロゾル組成物
KR20070000476A (ko) * 2004-02-27 2007-01-02 키에시 파르마슈티시 엣스. 피. 에이. 압축화 계량된 도스흡입용 안정된 약제용액 제제
EP1595531A1 (en) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
UA88894C2 (ru) * 2004-02-27 2009-12-10 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Стабильные фармацевтические композиции в виде растворов для ингаляторов с дозатором, которые находятся под давлением
ES2391563T5 (es) 2004-07-02 2022-10-26 Boehringer Ingelheim Int Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor
NZ556376A (en) 2005-02-25 2010-01-29 Chiesi Farma Spa Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
WO2006105401A2 (en) * 2005-03-30 2006-10-05 Schering Corporation Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US8227027B2 (en) 2007-12-07 2012-07-24 Presspart Gmbh & Co. Kg Method for applying a polymer coating to an internal surface of a container
CA2793170C (en) 2010-03-15 2018-04-17 Virginia Commonwealth University Aerosolized dapsone as a therapy for inflammation of the airway and abnormal mucociliary transport
EP2593108A2 (en) * 2010-07-16 2013-05-22 Cilpa Limited Pharmaceutical compositions comprising r(+) budesonide and one or more bronchodilators
TWI399202B (zh) 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
GB201108039D0 (en) * 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
CN102379846B (zh) * 2011-10-21 2014-07-02 江苏长风药业有限公司 以氢氟烷烃和聚乙二醇为辅料氟替卡松丙酸酯气雾剂制剂
GB201200525D0 (en) * 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
CN103207032A (zh) * 2012-01-13 2013-07-17 热敏碟公司 低型面温度传感器探针
KR101313993B1 (ko) * 2012-07-24 2013-10-01 한국화학연구원 약물 흡입 장치
DE102013214601B3 (de) * 2013-07-25 2014-05-22 Aptar Radolfzell Gmbh Gehäuse für eine Inhalationsvorrichtung und Inhalationsvorrichtung zur oralen Verabreichung eines pharmazeutischen Mediums
US10034866B2 (en) * 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
WO2015200049A1 (en) * 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Mdi related products and methods of use
SG10202109116YA (en) 2014-09-08 2021-09-29 Becton Dickinson Co System and method for preparing a pharmaceutical compound
CN106620976B (zh) * 2016-12-28 2020-01-07 四川普锐特医药科技有限责任公司 一种丙酸氟替卡松定量吸入气雾剂
US10231948B2 (en) 2017-02-27 2019-03-19 Jason Ty Nguyen Metered dose inhaler compositions, systems, and methods
US20210244896A1 (en) * 2018-06-13 2021-08-12 Puff-Ah Pty Ltd Apparatus for use in delivering respiratory drugs

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US220718A (en) * 1879-10-21 Improvement in street-car warmers
US154013A (en) * 1874-08-11 Improvement in carriage-lamps
BE555319A (es) * 1956-03-21 1900-01-01
US3361306A (en) * 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
CA882187A (en) 1968-03-13 1971-09-28 Farbenfabriken Bayer Aktiengesellschaft Thermoplastic-elastic moulding compounds
US3622053A (en) * 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
MX3864E (es) 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4185100A (en) 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
IT1196142B (it) 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en) * 1985-01-03 1986-04-22 David Rubin Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
WO1991012596A1 (de) 1990-02-14 1991-08-22 Systec Ausbausysteme Gmbh Transportwagen mit münzschloss
IT1244441B (it) * 1990-09-13 1994-07-15 Chiesi Farma Spa Dispositivo per l'inalazione boccale di farmaci aerosol
CA2098298A1 (en) 1990-12-19 1992-06-20 Susan M. Milosovich Aerosol formulations
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE69227189T2 (de) 1991-05-21 1999-02-25 Abbott Lab Aerosolinhalationsvorrichtung
WO1993004718A1 (de) * 1991-08-29 1993-03-18 Sroka, Peter-Christian Medizinisches gerät zur inhalation von dosier-aerosolen
IL103238A (en) 1991-09-25 1995-07-31 Fisons Plc Pressed aerosol preparations
US5219882A (en) 1991-10-24 1993-06-15 Emil Bisaccia Treatment methods for lymes disease and associated debilitating conditions
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
ATE150296T1 (de) 1991-12-18 1997-04-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
DE4230876A1 (de) 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
KR100312357B1 (ko) * 1992-12-09 2002-04-24 데이비드 이. 프랭크하우저 안정화된약제의에어로졸용액제제
SE9203743D0 (sv) 1992-12-11 1992-12-11 Astra Ab Efficient use
WO1994014490A1 (de) 1992-12-23 1994-07-07 Bernhard Hugemann Verfestigter arzneistoffvorrat für die mechanische erzeugung inhalierbarer wirkstoffpartikel
DE69405719T2 (de) 1993-03-17 1998-01-15 Minnesota Mining & Mfg Aerosolzubereitung, enthaltend ein aus einem diol-disäure-derivat abgeleitetes dispergiermittel
CA2156408C (en) 1993-03-17 2005-02-15 Daniel C. Duan Aerosol formulation containing a polyester dispersing aid
US5899201A (en) * 1993-05-26 1999-05-04 Minnesota Mining And Manufacturing Company Aerosol actuator
US6596260B1 (en) * 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
AU680967B2 (en) 1993-12-20 1997-08-14 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
GB9425160D0 (en) 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
CZ288146B6 (en) 1994-12-22 2001-05-16 Astra Ab Pharmaceutical aerosol preparation, process of its preparation and use
GB9426252D0 (en) 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
DE4446891A1 (de) 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US5653961A (en) 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
HUP9800641A3 (en) * 1995-04-14 2001-04-28 Glaxo Wellcome Inc Res Triangl Metered dose inhaler for beclomethasone dipropionate
DE69622166T2 (de) * 1995-04-14 2003-04-03 Smithkline Beecham Corp Dosierinhalator für albuterol
PL180895B1 (pl) * 1995-04-14 2001-04-30 Glaxo Wellcome Inc Inhalator z dozymetrem
NZ306280A (en) 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler for salmeterol
US5637505A (en) * 1995-05-19 1997-06-10 Chiron Diagnostics Corporation Method to prepare dye-based reference material
GB9526392D0 (en) * 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
EP0914143A1 (en) 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
WO1998003533A1 (en) 1996-07-24 1998-01-29 Oligos Etc. And Oligos Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9620187D0 (en) 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
NZ336049A (en) * 1996-12-04 2000-09-29 Bioglan Ireland R & D Ltd Aersol device for administering pharmaceutical active agents in a solution of propellant, carrier and valve means for delivering this to the exterior of the container
AUPO429396A0 (en) * 1996-12-20 1997-01-23 Solsearch Pty Ltd Solar energy collector system
AU718967B2 (en) * 1997-02-05 2000-05-04 Jagotec Ag Medical aerosol formulations
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US5891419A (en) 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
PT991734E (pt) 1997-06-12 2002-02-28 Pac Holding Sa Processo para a eliminacao de produtos residuais que contem hidrocarbonetos e/ou derivados halogenados
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
BR7702049U (pt) 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
US6045784A (en) * 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
ES2211108T3 (es) 1998-06-18 2004-07-01 Boehringer Ingelheim Pharmaceuticals Inc. Formulaciones farmaceuticas para aerosoles con dos o mas sustancias activas.
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
EP1100465B1 (de) 1998-07-24 2004-11-24 Jago Research Ag Medizinische aerosolformulierungen
US6475467B1 (en) 1998-08-04 2002-11-05 Jago Research Ag Medicinal aerosol formulations
DE19847969A1 (de) 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
WO2000023065A2 (de) 1998-10-17 2000-04-27 Boehringer Ingelheim Pharma Kg Lagerfähiges wirkstoffkonzentrat mit formoterol
US6086379A (en) * 1998-10-20 2000-07-11 Research Foundation Of State University Of New York System and method for training a swimmer
PT1283036E (pt) 1998-11-13 2008-03-06 Jagotec Ag Inalador de pó seco de dose múltipla com um reservatório de pó
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
WO2000053157A1 (en) 1999-03-05 2000-09-14 Chiesi Farmaceutici S.P.A. Improved powdery pharmaceutical compositions for inhalation
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
ES2238334T3 (es) 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
ME00220B (me) * 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
SI1273292T1 (en) * 2001-07-02 2004-12-31 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
ME00077B (me) 2002-03-01 2010-06-10 Chiesi Farm Spa Formoterol najfiniji preparat
EP1340492A1 (en) 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
US6808684B2 (en) 2002-04-05 2004-10-26 International Flavors & Fragrance Inc. Fragrance material
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Also Published As

Publication number Publication date
NO20012516L (no) 2001-07-23
DK1131051T3 (da) 2006-04-18
EP1131051B1 (en) 2006-01-04
EP1523975A2 (en) 2005-04-20
US8142763B2 (en) 2012-03-27
HK1040063A1 (en) 2002-05-24
US20080115782A1 (en) 2008-05-22
CN1200690C (zh) 2005-05-11
HU226735B1 (en) 2009-08-28
SI1131051T1 (sl) 2006-04-30
US7223381B2 (en) 2007-05-29
CO5170487A1 (es) 2002-06-27
EA004132B1 (ru) 2003-12-25
AR021391A1 (es) 2002-07-17
US20080247965A1 (en) 2008-10-09
KR20010080543A (ko) 2001-08-22
DE29923839U1 (de) 2001-03-01
NZ511926A (en) 2003-10-31
CA2352484C (en) 2010-05-04
GEP20033129B (en) 2003-12-25
PL348717A1 (en) 2002-06-03
SK285246B6 (sk) 2006-09-07
TR200101441T2 (tr) 2001-08-21
SA99200825B1 (ar) 2006-11-07
US20050142071A1 (en) 2005-06-30
PL200658B1 (pl) 2009-01-30
EP1523975B1 (en) 2010-10-27
NZ527190A (en) 2005-04-29
US20030089369A1 (en) 2003-05-15
US20040096399A1 (en) 2004-05-20
EA200100468A1 (ru) 2001-12-24
EG25278A (en) 2011-12-05
EP1674079A3 (en) 2006-07-05
WO2000030608A1 (en) 2000-06-02
CY1105356T1 (el) 2010-03-03
US7347199B1 (en) 2008-03-25
KR100696746B1 (ko) 2007-03-19
MA26764A1 (fr) 2004-12-20
CN1328445A (zh) 2001-12-26
EP1666029A1 (en) 2006-06-07
US7740463B2 (en) 2010-06-22
IL143294A (en) 2007-05-15
ATE485812T1 (de) 2010-11-15
HUP0104411A3 (en) 2002-12-28
EE200100276A (et) 2002-12-16
NO330194B1 (no) 2011-03-07
BR9916868A (pt) 2001-11-06
BG105532A (bg) 2001-12-29
ATE314838T1 (de) 2006-02-15
IL179491A0 (en) 2007-05-15
AU1556300A (en) 2000-06-13
EP1674079A2 (en) 2006-06-28
CZ301305B6 (cs) 2010-01-06
AU764696C (en) 2004-06-24
US20030066525A1 (en) 2003-04-10
PL204572B1 (pl) 2010-01-29
CA2698376A1 (en) 2000-06-02
EP1131051A1 (en) 2001-09-12
SK7042001A3 (en) 2001-11-06
EP1523975A3 (en) 2005-08-31
DE69929358D1 (de) 2006-03-30
CZ20011834A3 (cs) 2001-12-12
ES2255767T3 (es) 2006-07-01
AU764696B2 (en) 2003-08-28
BR9916868B1 (pt) 2011-02-08
TNSN99220A1 (fr) 2001-12-31
IL143294A0 (en) 2002-04-21
DE69942896D1 (de) 2010-12-09
JP2002530156A (ja) 2002-09-17
HK1040063B (zh) 2006-04-21
BG65596B1 (bg) 2009-02-27
HUP0104411A2 (hu) 2002-03-28
TWI226247B (en) 2005-01-11
US20110100361A1 (en) 2011-05-05
DE69929358T2 (de) 2006-07-13
NO20012516D0 (no) 2001-05-22
TR200704956T2 (tr) 2008-01-21
DZ2947A1 (fr) 2004-03-15
CA2352484A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
EE200100276A (et) Survestatud doseerivad inhalaatorid (MDId)
EE04005B1 (et) Salmeterooli doseeriv inhalaator
BR9604978A (pt) Inalador com dose medida
LTPA2011011I1 (lt) Stabilūs farmacinių tirpalų preparatai, skirti slėginiams dozuotiems inhaliatoriams
EE9700280A (et) Albuterooli doseeriv inhalaator
PL369072A1 (en) Metered dose inhaler
NO20011383L (no) Inhalator
AU4417101A (en) Metered dose inhaler
AU2001256168A1 (en) Metered dose inhaler
AU4831801A (en) Metered dose inhaler
AU4417001A (en) Metered dose inhaler
GB0020978D0 (en) Metered dose inhaler
HU0800754D0 (en) Ressurised metered dose inhalers
GB0004761D0 (en) Metered dose inhaler
GB0018684D0 (en) Metered dose inhaler
GB0004763D0 (en) Metered dose inhaler
GB0018685D0 (en) Metered dose inhaler
GB0018653D0 (en) Metered dose inhaler
GB0018625D0 (en) Metered dose inhaler
GB0018652D0 (en) Metered dose inhaler
GB0018675D0 (en) Metered dose inhaler
GB0018674D0 (en) Metered dose inhaler
GB0018624D0 (en) Metered dose inhaler
GB0004794D0 (en) Metered dose inhaler
GB0004798D0 (en) Metered dose inhaler

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231